Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.

Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)

Open access
Benedé-Ubieto, Raquel, Cubero, Francisco Javier, Nevzorova, Yulia A. · 2024 · Gut Microbes

Abstract

Obesity, insulin resistance (IR), and the gut microbiome intricately interplay in Metabolic-associated Steatotic Liver Disease (MASLD), previously known as Non-Alcoholic Fatty Liver Disease (NAFLD), a growing health concern. The complex progression of MASLD extends beyond the liver, driven by "gut-liver axis," where diet, genetics, and gut-liver interactions influence disease development. The pathophysiology of MASLD involves excessive liver fat accumulation, hepatocyte dysfunction, inflammation, and fibrosis, with subsequent risk of hepatocellular carcinoma (HCC). The gut, a tripartite barrier, with mechanical, immune, and microbial components, engages in a constant communication with the liver. Recent evidence links dysbiosis and disrupted barriers to systemic inflammation and disease progression. Toll-like receptors (TLRs) mediate immunological crosstalk between the gut and liver, recognizing microbial structures and triggering immune responses. The "multiple hit model" of MASLD development involves factors like fat accumulation, insulin resistance, gut dysbiosis, and genetics/environmental elements disrupting the gut-liver axis, leading to impaired intestinal barrier function and increased gut permeability. Clinical management strategies encompass dietary interventions, physical exercise, pharmacotherapy targeting bile acid (BA) metabolism, and microbiome modulation approaches through prebiotics, probiotics, symbiotics, and fecal microbiota transplantation (FMT). This review underscores the complex interactions between diet, metabolism, microbiome, and their impact on MASLD pathophysiology and therapeutic prospects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/19490976.2024.2331460

Cites

185 of 185 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. A. Epithelium organization of the small intestine. Graphical representation of villi, crypts and different type of intestinal cells. B. Colon epithelium. Graphical representation of crypts and different type of colonic cells. Figure created with BioRender.com.
Figure 1. A. Epithelium organization of the small intestine. Graphical representation of villi, crypts and different type of intestinal cells. B. Colon epithelium. Graphical representation of crypts and different type of colonic cells. Figure created with BioRender.com.CC BY · PubMed Central
Figure 2. Gut mechanical barrier components. 1. Mucus layer is the outer mechanical barrier composed by mucus. 2. Epithelial cells: enterocytes, goblet cells, enteroendocrine cells, Paneth cells and microfold cells. 3. Tight junctions (TJs) are composed of proteins that control the paracellular pathway, as well as adherent junctions, desmosomes, and gap junctions. 4. Gut vascular barrier (GVB) constitutes the inner layer of defense, and it is composed by endothelial cells linked by TJs among others and different proteins that play a fundamental role regulating blood vessel permeability. Figure created with BioRender.com.
Figure 2. Gut mechanical barrier components. 1. Mucus layer is the outer mechanical barrier composed by mucus. 2. Epithelial cells: enterocytes, goblet cells, enteroendocrine cells, Paneth cells and microfold cells. 3. Tight junctions (TJs) are composed of proteins that control the paracellular pathway, as well as adherent junctions, desmosomes, and gap junctions. 4. Gut vascular barrier (GVB) constitutes the inner layer of defense, and it is composed by endothelial cells linked by TJs among others and different proteins that play a fundamental role regulating blood vessel permeability. Figure created with BioRender.com.CC BY · PubMed Central
Figure 3. Photomicrograph of immunofluorescence (IF) preparation of colon stained with mucin-2 antibody. Nuclei are stained in blue. Staining was performed in 5 μm sections from paraffin embedded colon from a C57Bl/6J mouse 20 weeks age fed with chow diet. Scale = 100 μm.
Figure 3. Photomicrograph of immunofluorescence (IF) preparation of colon stained with mucin-2 antibody. Nuclei are stained in blue. Staining was performed in 5 μm sections from paraffin embedded colon from a C57Bl/6J mouse 20 weeks age fed with chow diet. Scale = 100 μm.CC BY · PubMed Central
Figure 4. Schematic representation of TJ in gut. The paracellular pathway is controlled by a group of proteins known as junctional complexes that include, adherent junctions, gap junctions and tight junctions (composed by transmembrane proteins as claudins, occludin and junctional adhesion molecules (JAM)) which interact with the zona occludens (ZO) family of scaffolding proteins and the cytoskeletal actomyosin ring. Figure created with BioRender.com.
Figure 4. Schematic representation of TJ in gut. The paracellular pathway is controlled by a group of proteins known as junctional complexes that include, adherent junctions, gap junctions and tight junctions (composed by transmembrane proteins as claudins, occludin and junctional adhesion molecules (JAM)) which interact with the zona occludens (ZO) family of scaffolding proteins and the cytoskeletal actomyosin ring. Figure created with BioRender.com.CC BY · PubMed Central
Figure 5. Photomicrograph of immunofluorescence (IF) preparation of colon stained with ZO-1. Nuclei are stained in blue. Staining was performed in 5 μm sections from paraffin embedded colon from a C57Bl/6J mouse 20 weeks age fed with chow diet. mounting. Scale = 100 μm.
Figure 5. Photomicrograph of immunofluorescence (IF) preparation of colon stained with ZO-1. Nuclei are stained in blue. Staining was performed in 5 μm sections from paraffin embedded colon from a C57Bl/6J mouse 20 weeks age fed with chow diet. mounting. Scale = 100 μm.CC BY · PubMed Central
Figure 6. Representative photomicrograph of hematoxylin and eosin (H&E) staining in distal colon. Staining was performed in 5 μm sections from paraffin embedded colon from a C57Bl/6J mouse 20 weeks age fed with chow diet. GALT structure is marked with an arrow. Scale = 100 μm.
Figure 6. Representative photomicrograph of hematoxylin and eosin (H&E) staining in distal colon. Staining was performed in 5 μm sections from paraffin embedded colon from a C57Bl/6J mouse 20 weeks age fed with chow diet. GALT structure is marked with an arrow. Scale = 100 μm.CC BY · PubMed Central
Figure 7. Immune barrier. Immune cells are mainly located in the gut mucose where secretory immunoglobulin a (SIgA) can be found. Gut barrier include macrophages, lymphocytes, paneth cells (more abundant in the small intestine) and microfold cells (M). Moreover, the gut-associated lymphoid tissue (GALT) is located in the lamina propria and can be classified into Peyer’s patches (PP) or isolated lymphoid follicles. Figure created with BioRender.com.
Figure 7. Immune barrier. Immune cells are mainly located in the gut mucose where secretory immunoglobulin a (SIgA) can be found. Gut barrier include macrophages, lymphocytes, paneth cells (more abundant in the small intestine) and microfold cells (M). Moreover, the gut-associated lymphoid tissue (GALT) is located in the lamina propria and can be classified into Peyer’s patches (PP) or isolated lymphoid follicles. Figure created with BioRender.com.CC BY · PubMed Central
Figure 8. Enterohepatic BA cycle. Bile synthesis is performed in the liver by Cyp7a1 and Cyp27a11 enzymes. When synthesis is completed, BA are released in the bile canaliculi through the BSEP pump and stored in the gallbladder. In the ileum, bile salts are absorbed by ASBT and efluxed by OST-α/β to the circulation. Back to the liver they are uptaken by NTCP, a transporter located in the basolateral membrane of the hepatocytes. ABST, apical sodium-bile acid transporter; BSEP, bile salt export pump; FXR, farnesoid X receptor; NTCP, sodium taurocholate co-transporting polypeptide; OST, organic solute transporter.
Figure 8. Enterohepatic BA cycle. Bile synthesis is performed in the liver by Cyp7a1 and Cyp27a11 enzymes. When synthesis is completed, BA are released in the bile canaliculi through the BSEP pump and stored in the gallbladder. In the ileum, bile salts are absorbed by ASBT and efluxed by OST-α/β to the circulation. Back to the liver they are uptaken by NTCP, a transporter located in the basolateral membrane of the hepatocytes. ABST, apical sodium-bile acid transporter; BSEP, bile salt export pump; FXR, farnesoid X receptor; NTCP, sodium taurocholate co-transporting polypeptide; OST, organic solute transporter.CC BY · PubMed Central
Figure 9. TLR types. TLR1, 2, 4, 5 and 6 bind to molecules associated with bacterial membranes. Concretely, TLR4, one of the most studied TLRs, binds to the LPS from the Gram-negative bacteria cell wall. TLR3, 7, 8 and 9 recognize viral, bacterial, or endogenous nucleic acids. Immune response initiation is mediated by TLR activation. DAMP, damage associated molecular patterns; LPS, lipopolysaccharide; PAMP, pathogen associated molecular patterns; TLR, toll-like receptor.
Figure 9. TLR types. TLR1, 2, 4, 5 and 6 bind to molecules associated with bacterial membranes. Concretely, TLR4, one of the most studied TLRs, binds to the LPS from the Gram-negative bacteria cell wall. TLR3, 7, 8 and 9 recognize viral, bacterial, or endogenous nucleic acids. Immune response initiation is mediated by TLR activation. DAMP, damage associated molecular patterns; LPS, lipopolysaccharide; PAMP, pathogen associated molecular patterns; TLR, toll-like receptor.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 185 references

Cited by

See all 242

Metadata

Authors
Benedé-Ubieto, R., Cubero, F. J., & Nevzorova, Y. A.
Affiliations
  • Department of Immunology, Ophthalmology and ENT, Complutense University School of Medicine, Madrid, Spain
  • Universidad Complutense de Madrid (ES)
Corresponding author
Nevzorova, Yulia A.
Venue
Gut Microbes
Published
2024-03-21
Volume
16
Issue
1
Pages
2331460-2331460
ISSN
  • 1949-0976 (ISSN-L)
  • 1949-0984
OpenAlex
W4393033456
Cited by
242
References
185
Citations by year
2026: 106 · 2025: 106 · 2024: 30
FWCI
15.90
Type
journal article
Language
en
Open access
Locations
  • Gut Microbes (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • MICINN (PID2020-117827RB-IOO/AEI/10.13039/501100011033)
  • Comunidad de Madrid
  • Universidad Complutense de Madrid (CT63/19)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
non-alcoholic fatty liver disease, gut-liver axis, gut dysbiosis, intestinal barrier function, intestinal permeability, insulin resistance, obesity, Toll-like receptors, liver inflammation, liver fibrosis, hepatocellular carcinoma, bile acid metabolism, prebiotics, probiotics, fecal microbiota transplantation, microbiota modulation, dietary intervention, physical activity
MeSH terms
Gastrointestinal Microbiome, Carcinoma, Hepatocellular, Homeostasis, Humans, Inflammation, Insulin Resistance, Liver Neoplasms, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD). https://app.cochat.ai/papers/10.1080/19490976.2024.2331460
The paper
Benedé-Ubieto, R., Cubero, F. J., & Nevzorova, Y. A. (2024). Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD). Gut Microbes. https://doi.org/10.1080/19490976.2024.2331460

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.